Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Oncolys Biopharma revises term to receive subsidy from NEDO

Wednesday, 14 May 2014 05:45am EDT 

Oncolys Biopharma Inc:To receive subsidy up to 125,313,000 yen from New Energy and Industrial Technology Development Organization (NEDO), for development of epigenetic drug for metastatic renal cell carcinoma patient, from late May 2014 to Feb. 28, 2015. 

Company Quote

11.0 +1.40%
27 Jan 2015